Found 9 matching trials
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma PHASE2 This is a study to evaluate the efficacy and safety of preoperative treatme...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer PHASE3 NEEDS is a pragmatic open-label, randomised, controlled, phase III, multice...
Show More Location
McGill University Health Centre
Learn More & Join Trial
Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Learn More & Join Trial
PDL-1 Targeting in Resectable Oesophageal Cancer PHASE2 Objectives The primary objective of this study is to assess the feasibility...
Show More Location
Academic Medical Center, Medical Oncology
Learn More & Join Trial
Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients PHASE3 This randomized Phase III study aims to show major complication rate of hyp...
Show More Location
Multiple Locations
Learn More & Join Trial
Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. PHASE1 Open-label, single-center phase 1 study of an investigational agent TH-302 ...
Show More Location
Multiple Locations
Learn More & Join Trial
NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma PHASE1 This study is a prospective single arm trial designed to study the safety, ...
Show More Location
John Theurer Cancer Center at Hackensack University Medical Center
Learn More & Join Trial
Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy PHASE2 The primary objective of this study is to investigate whether two weeks of ...
Show More Learn More & Join Trial
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma PHASE1 The purpose of this trial is to show proof of concept that by blocking the ...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial